Activation of the stress-activated JNK and p38 MAP kinases in human cells by Photofrin-mediated photodynamic therapy

Journal of Photochemistry and Photobiology B: Biology

Volumn 71, Issue 1-3, 2003, Pages 77-85

  Tong, Zhimin ^a,b   Singh, Gurmit ^a,b   Valerie, Kristoffer ^c   Rainbow, Andrew J ^a  

^a MCMASTER UNIVERSITY   (Canada)

^b JURAVINSKI CANCER CENTRE   (Canada)

^c VIRGINIA COMMONWEALTH UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

JNK; p38; PDT; Photofrin; Sensitivity

Indexed keywords

MITOGEN ACTIVATED PROTEIN KINASE; MUTANT PROTEIN; PHOTOFRIN; STRESS ACTIVATED PROTEIN KINASE; SYNAPTOPHYSIN;

ARTICLE; CANCER CELL; CELL ACTIVITY; CELL IMMORTALIZATION; CELL SURVIVAL; CELL TYPE; CONTROLLED STUDY; DOMINANT GENE; ENZYME ACTIVATION; ENZYME INDUCTION; FIBROBLAST; GENETIC TRANSFECTION; HELA CELL; HUMAN; HUMAN CELL; PHOTODYNAMIC THERAPY; PRIORITY JOURNAL; STRESS; VIRUS INFECTION; VIRUS RECOMBINANT;

ADENOVIRIDAE;

EID: 0141961613     PISSN: 10111344     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jphotobiol.2003.08.001     Document Type: Article

References (51)

1. T.S. Lewis, P.S. Shapiro, N.G. Ahn, Signal transduction through MAP kinase cascades, Adv. Cancer Res. 74 (1998) 49-139.
2. A.J. Whitmarsh, R.J. Davis, Transcription factor AP-1 regulation by mitogen-activated protein kinase signal transduction pathways, J. Mol. Med. 74 (1996) 589-607.
3. J.M. Kyriakis, J. Avruch, Protein kinase cascades activated by stress and inflammatory cytokines, Bioessays 18 (1996) 567-577.
4. C.J. Marshall, Specificity of receptor tyrosine kinase signaling: transient versus sustained extracellular signal-regulated kinase activation, Cell 80 (1995) 179-185.
5. L.O. Klotz, C. Fritsch, K. Briviba, N. Tsacmacidis, F. Schliess, H. Sies, Activation of JNK and p38 but not ERK MAP kinases in human skin cells by 5-aminolevulinate-photodynamic therapy, Cancer Res. 58 (1998) 4297-4300.
6. J.C. Lee, S. Kassis, S. Kumar, A. Badger, J.L. Adams, p38 mitogen-activated protein kinase inhibitors - mechanisms and therapeutic potentials, Pharmacol. Ther. 82 (1999) 389-397.
7. J.M. Kyriakis, P. Banerjee, E. Nikolakaki, T. Dai, E.A. Rubie, M.F. Ahmad, J. Avruch, J.R. Woodgett, The stress-activated protein kinase subfamily of c-Jun kinases, Nature 369 (1994) 156-160.
8. Y. Nagata, K. Todokoro, Requirement of activation of JNK and p38 for environmental stress-induced erythroid differentiation and apoptosis and of inhibition of ERK for apoptosis, Blood 94 (1999) 853-863.
9. D.V. Bulavin, S. Saito, M.C. Hollander, K. Sakaguchi, C.W. Anderson, E. Appella, A.J. Fornace, Phosphorylation of the human p53 by p38 kinase coordinates N-terminal phosphorylation and apoptosis to UV radiation, EMBO 18 (1999) 6848-6854.
10. S.M. Chuang, I.C. Wang, J.L. Yang, Roles of JNK, p38 and ERK mitogen-activated protein kinases in the growth inhibition and apoptosis induced by cadmium, Carcinogenesis 21 (2000) 1423-1432.
11. N. Chinouinard, K. Valerie, M. Rouabhia, J. Huot, UVB-mediated activation of p38 mitogen-activated protein kinase ehances resistance of normal human keratinocytes to apoptosis by stabilizing cytoplasmic p53, Biochem. J. 365 (2002) 133-145.
12. N.L. Johnson, A.M. Gardner, K.M. Diener, C.A. Lange-Carter, J.M.B. Jarpe, A. Minden, M. Karin, L.I. Zon, G.L. Johnson, Signal transduction pathways regulated by mitogen-activated extracellular response kinase kinase kinase induce cell death, J. Biol. Chem. 271 (1996) 3229-3237.
13. Z. Xia, M. Dickens, J. Raingeaud, R.J. Davis, M.E. Greenberg, Opposing effects of ERK and JNK-p38 MAP kinases on apoptosis, Science 270 (1995) 1326-1331.
14. Z.G. Liu, H. Hsu, D.V. Goeddel, M. Karin, Dissection of TNF receptor 1 effector functions: JNK activation is not linked to apoptosis while NF-kappaB activation prevents cell death, Cell 87 (1996) 565-576.
15. K. Tsukahara, A. Nakao, M. Hiraguri, S. Miike, M. Mamura, Y. Saito, I. Iwamoto, Tumor necrosis factor-alpha mediates antiapoptotic signals partially via p38 MAP kinase activation in human eosinophils, Int. Arch. Allergy Immunol. 120 (Suppl 1) (1999) 54-59.
16. O. Potapova, A. Haghighi, F. Bost, C. Liu, M.J. Birrer, R. Gjerset, D. Mercola, The Jun kinase/stress-activated protein kinase pathway functions to regulate DNA repair and inhibition of the pathway sensitizes tumor cells to cisplatin, J. Biol. Chem. 272 (1997) 14041-14044.
17. I. Georgakoudi, T.H. Foster, Singlet oxygen- versus nonsinglet oxygen-mediated mechanisms of sensitizer photobleaching and their effects on photodynamic dosimetry, Photochem. Photobiol. 67 (1998) 612-625.
18. T.J. Dougherty, C.J. Gomer, B.W. Henderson, G. Jori, D. Kessel, M. Korbelik, J. Moan, Q. Peng, Photodynamic therapy, J. Natl. Cancer Inst. 90 (1998) 889-905.
19. J.S. McCaughan, Photodynamic therapy: a review, Drugs Aging 15 (1999) 49-68.
20. M.T. Foultier, T. Patrice, V. Praloran, N. Robillard, L. Le Bodic, Influence of hematoporphyrin derivative concentration, incubation time, temperature during incubation and laser dose fractionation on photosensitivity of normal hemopoietic progenitors or leukemic cells, Biochimie 71 (1989) 819-825.
21. P.C. Dartsch, T. Ischinger, E. Betz, Responses of cultured smooth muscle cells from human nonatherosclerotic arteries and primary stenosing lesions after photoradiation: implications for photodynamic therapy of vascular stenoses, J. Am. Coll. Cardiol. 15 (1990) 1545-1550.
22. J.V. Moore, C.M. West, C. Whitehurst, The biology of photodynamic therapy, Phys. Med. Biol. 42 (1997) 913-935.
23. Z. Assefa, A. Vantieghem, W. Declercq, P. Vandenabeele, J.R. Vandenheede, W. Merlevede, P. de Witte, P. Agostinis, The activation of the c-Jun N-terminal kinase and p38 mitogen-activated protein kinase signaling pathways protects HeLa cells from apoptosis following photodynamic therapy with hypericin, J. Biol. Chem. 274 (1999) 8788-8796.
24. L. Xue, J. He, N.L. Oleinick, Promotion of photodynamic therapy-induced apoptosis by stress kinases, Cell Death Differ. 6 (1999) 855-864.
25. Y.-J. Hsieh, C.-C. Wu, C.-J. Chang, J.-S. Yu, Subcellular localization of Photofrin determines the death phenotype of human epidermoid carcinoma A341 cells triggered by photodynamic therapy: when plasma membranes are the main targets, J. Cell. Physiol. 194 (2003) 365-375.
26. Z. Tong, G. Singh, A.J. Rainbow, The role of the p53 tumor suppressor in the response of human cells to Photofrin-mediated photodynamic therapy, Photochem. Photobiol. 71 (2000) 201-210.
27. M.M. Taber, T. Baumgardner, P. Dent, K. Valerie, Genetic evidence that stress-activated p38 MAP kinase is necessary but not sufficient for UV activation of HIV gene expression, Biochemistry 38 (1999) 13055-13062.
28. D. Sarkar, Z.Z. Su, I.V. Lebedeva, M. Sauane, R.V. Gopalkrishnan, K. Valerie, P. Dent, P.B. Fisher, mda-7 (IL-24) mediates selective apoptosis in human melanoma cells by inducing the coordinated overexpression of the GADD family of genes by mean of p38 MAPK, PNAS 99 (2002) 10054-10059.
29. M.A. Morsy, E.L. Alford, A. Bett, F.L. Graham, T. Caskey, Efficient adenoviral-mediated ornithine transcarboxylase expression in deficient mouse and human hepatocytes, J. Clin. Investig. 92 (1993) 1580-1586.
30. K. Endo, I. Kurantate, M. Watanabe, H. Yoshida, R. Teshima, M. Osaki, H. Ito, Wild-type p53 gerne transfection in human cultured sarcomas: effect of CDDP, Oncol. Rep. 8 (2001) 637-642.
31. F.L. Graham, L. Prevec, Manipulation of adenovirus vectors, in: E.J. Murray (Ed.), Gene Transfer and Expression Protocols, vol. 7, The Humana Press, Clifton, 1991, pp. 109-128.
32. Z. Assefa, A. Vantieghem, W. Declercq, P. Vandenabeele, J.R. Vandenheede, W. Merlevede, P. de Witte, P. Agostinis, The activation of the c-Jun N-terminal kinase and p38 mitogen-activated protein kinase signaling pathways protects HeLa cells from apoptosis following photodynamic therapy with hypericin, J. Biol. Chem. 274 (1999) 8788-8796.
33. J. Raingeaud, S. Gupta, J.S. Rogers, M. Dickens, J. Han, R.J. Ulevitch, R.J. Davis, Pro-inflammatory cytokines and environmental stress cause p38 mitogen-activated protein kinase activation by dual phosphorylation on tyrosine and threonine, J. Biol. Chem. 270 (1995) 7420-7426.
34. L. Xue, J. He, N.L. Oleinick, Promotion of photodynamic therapy-induced apoptosis by stress kinases, Cell Death Differ. 6 (1999) 855-864.
35. D.P. Buchczyk, L.O. Klotz, K. Lang, C. Fritsch, H. Sies, High efficiency of 5-aminolevulinate-photodynamic treatment using UVA irradiation, Carcinogenesis 22 (2002) 879-883.
36. L.O. Klotz, C. Fritsch, K. Briviba, N. Tsacmacidis, F. Schliess, H. Sies, Activation of JNK and p38 but not ERK MAP kinases in human skin cells by 5-aminolevulinate-photodynamic therapy, Cancer Res. 58 (1998) 4297-4300.
37. K.G. Mendelson, L.R. Contois, S.G. Tevosian, R.J. Davis, K.E. Paulson, Independent regulation of JNK/p38 mitogen-activated protein kinases by metabolic oxidative stress in the liver, Proc. Natl. Acad. Sci. USA 93 (1996) 12908-12913.
38. L.O. Klotz, K. Briviba, H. Sies, Singlet oxygen mediates the activation of JNK by UVA radiation in human skin fibroblasts, FEBS Lett. 408 (1997) 289-291.
39. J.Y. Matroule, J. Piette, Photosensitization and redox signaling, Antioxid. Redox. Signal. 2 (2000) 301-315.
40. J. Tao, J.S. Sanghera, S.L. Pelech, G. Wong, J.G. Levy, Stimulation of stress-activated protein kinase and p38 HOG1 kinase in murine keratinocytes following photodynamic therapy with benzoporphyrin derivative, J. Biol. Chem. 271 (1996) 27107-27115.
41. V. Adler, Z. Yin, S.Y. Fuchs, M. Benezra, L. Rosario, K.D. Tew, M.R. Pincus, M. Sardana, C.J. Henderson, C.R. Wolf, R.J. Davis, Z. Ronai, Regulation of JNK signaling by GSTp, EMBO J. 18 (1999) 1321-1334.
42. M.G. Sanna, C.S. Duckett, B.W. Richter, C.B. Thompson, R.J. Ulevitch, Selective activation of JNK1 is necessary for the anti-apoptotic activity of hILP, Proc. Natl. Acad. Sci. USA 95 (1998) 6015-6020.
43. N. Sakata, H.R. Patel, N. Terada, A. Aruffo, G.L. Johnson, E.W. Gelfand, Selective activation of c-Jun kinase mitogen-activated protein kinase by CD40 on human B cells, J. Biol. Chem. 270 (1995) 30823-30828.
44. I. Berberich, G. Shu, F. Siebelt, J.R. Woodgett, J.M. Kyriakis, E.A. Clark, Cross-linking CD40 on B cells preferentially induces stress-activated protein kinases rather than mitogen-activated protein kinases, EMBO J. 15 (1996) 92-101.
45. Y.R. Chen, T.H. Tan, The c-Jun N-terminal kinase pathway and apoptotic signaling (review), Int. J. Oncol. 16 (2000) 651-662.
46. A. Mazars, C. Tournigand, P. Mollat, C. Prunier, N. Ferrand, M.F. Bourgeade, C. Gespach, A. Atfi, Differential roles of JNK and Smad2 signaling pathways in the inhibition of c-Myc-induced cell death by TGF-beta, Oncogene 19 (2000) 1277-1287.
47. X. Xu, O. Heidenreich, I. Kitajima, K. McGuire, Q. Li, B. Su, M. Nerenberg, Constitutively activated JNK is associated with HTLV-1 mediated tumorigenesis, Oncogene 13 (1996) 135-142.
48. Y. Hagens, G.I. Glaser, W. Davis, M. Eichhorn, D. Dobbelaere, Jun NH2-terminal kinase is constitutively activated in T cells transformed by the intracellular parasite Theileria parva, Proc. Natl. Acad. Sci. USA 94 (1997) 5119-5124.
49. B.Y. Kim, M.J. Han, A.S. Chung, Effects of reactive oxygen species on proliferation of Chinese hamster lung fibroblast (V79) cells, Free Radic. Biol. Med. 30 (2001) 686-698.
50. H. Hida, S. Nagano, M. Takeda, B. Soliven, Regulation of mitogen-activated protein kinases by sphingolipid products in oligodendrocytes, J. Neurosci. 19 (1999) 7458-7467.
51. Z. Tong, G. Singh, A.J. Rainbow, Sustained activation of the extracellular signal-regulated kinase pathway protects cells from photofrin-mediated photodynamic therapy, Cancer Res. 62 (2002) 5528-5535.